Local and Systemic Immunity against Respiratory Syncytial Virus Induced by a Novel Intranasal Vaccine. A Randomized, Double-Blind, Placebo-controlled Clinical Trial

Overview of attention for article published in American Journal of Respiratory & Critical Care Medicine, August 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

news: 2 news outlets

twitter: 22 X users

Readers on

mendeley: 100 Mendeley

So far, Altmetric has seen 28 X posts from 22 X users, with an upper bound of 127,503 followers.

@Mario55518 @simonmaechling https://t.co/12VsEq0T4W

@ventnostics @EricTopol @ScienceVisuals @Anandamirch @p_openshaw @ScienceMagazine Yes, IgA is also super important. Check out our previous paper in the same system https://t.co/sVnbEc7mk1

Local and Systemic Immunity against Respiratory Syncytial Virus Induced by a Novel Intranasal Vaccine. A Randomized, Double-Blind, Placebo-controlled Clinical Trial. https://t.co/bZ1STtmLqO

RT @RespirarGVR: SynGEM es la primera vacuna de subunidad de RSV intranasal no replicante que induce respuestas de anticuerpos persistente…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 24 additional X posts.